Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like CSL Behring Scoops Up This U.S. Biotech for $416 Million August 27, 2017 What Brent Saunders Thinks About a Possible Allergan Breakup October 19, 2017 Esperion's Cholesterol Drug Positive in PhIII Trial March 6, 2018
